e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Pulmonary circulation: clinical pulmonary hypertension II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical characteristics of scleroderma patients with and without pulmonary hypertension
A. Boutou, G. Pitsiou, N. Chavouzis, A. Paspala, E. Sourla, P. Argyropoulou, I. Stanopoulos (Thessaloniki, Greece)
Source:
Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Session:
Pulmonary circulation: clinical pulmonary hypertension II
Session type:
Thematic Poster Session
Number:
2640
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Boutou, G. Pitsiou, N. Chavouzis, A. Paspala, E. Sourla, P. Argyropoulou, I. Stanopoulos (Thessaloniki, Greece). Clinical characteristics of scleroderma patients with and without pulmonary hypertension. Eur Respir J 2013; 42: Suppl. 57, 2640
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
From pulmonary gas exchange to the interpretation of arterial blood gases
Related content which might interest you:
Scleroderma lung disease: Detection of pulmonary hypertension using pulmonary function tests is problematic in patients with emphysema
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
The impact of definition of ILD on WHO group Classification of PH in scleroderma
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Pulmonary hypertension in interstitial lung disease
Source: Eur Respir J 2008; 31: 1357-1367
Year: 2008
Acute effects of oxygen on pulmonary hemodynamic can help in differentiation of pulmonary hypertension at patients with connective tissue diseases
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Baseline characteristics and survival of patients with pulmonary hypertension in interstitial lung disease in the “HYPID” study
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013
Interstitial lung disease
Source: Eur Respir Rev 2013; 22: 26-32
Year: 2013
Pulmonary function involvement in scleroderma
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015
Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study
Source: Annual Congress 2013 –Pulmonary circulation: treatment
Year: 2013
Comorbidities in patients with the combined pulmonary fibrosis and emphysema syndrome (CPFE)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Pulmonary hypertension in patients with interstitial lung disease
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011
Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Study of factors affecting mortality in ILD cases over 2 years
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Significance of connective tissue disease features in idiopathic interstitial pneumonia
Source: Eur Respir J 2012; 39: 661-668
Year: 2012
A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Genomic comparison of fibrotic rheumatoid arthritis-associated ILD and idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Clinical features of usual interstitial pneumonia-correlation between idiopathic pulmonary fibrosis and connective tissue disease associated with usual interstitial pneumonia
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
ILD-India registry: Idiopathic pulmonary fibrosis (IPF) and connective tissue disease (CTD) associated interstitial lung disease (CTD-ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Clinical course and outcome of vasculitis related interstitial lung disease
Source: International Congress 2014 – ILDs 2
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept